| High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins. Schneider M., Witztum J.L., Young S.G., Ludwig E.H., Miller E.R., Tsimikas S., Curtiss L.K., Marcovina S.M., Taylor J.M., Lawn R.M. et al.
J. Lipid Res. 46:769-778(2005) · Mapped (11) |
| DGAT1 promoter polymorphism associated with alterations in body mass index, high density lipoprotein levels and blood pressure in Turkish women. Ludwig E.H., Mahley R.W., Palaoglu E., Ozbayrakci S., Balestra M.E., Borecki I.B., Innerarity T.L., Farese R.V. Jr.
Clin. Genet. 62:68-73(2002) · Mapped (2) |
| Essential role of NAT1/p97/DAP5 in embryonic differentiation and the retinoic acid pathway. Yamanaka S., Zhang X.Y., Maeda M., Miura K., Wang S., Farese R.V. Jr., Iwao H., Innerarity T.L.
EMBO J. 19:5533-5541(2000) · Mapped (10) |
| Phylogenetic analysis of the apolipoprotein B mRNA-editing region. Evidence for a secondary structure between the mooring sequence and the 3' efficiency element. Hersberger M., Patarroyo-White S., Arnold K.S., Innerarity T.L.
J. Biol. Chem. 274:34590-34597(1999) · Mapped (4) |
| Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors. Qian X., Balestra M.E., Yamanaka S., Boren J., Lee I., Innerarity T.L.
Arterioscler. Thromb. Vasc. Biol. 18:1013-1020(1998) · Mapped (4) |
| Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease, and receptor binding of low density lipoproteins. Ludwig E.H., Hopkins P.N., Allen A., Wu L.L., Williams R.R., Anderson J.L., Ward R.H., Lalouel J.M., Innerarity T.L.
J. Lipid Res. 38:1361-1373(1997) · Mapped (12) |
| A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme. Yamanaka S., Poksay K.S., Arnold K.S., Innerarity T.L.
Genes Dev. 11:321-333(1997) · UniProtKB (3) · Mapped (13) |
| Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia. Dong L.-M., Parkin S., Trakhanov S.D., Rupp B., Simmons T., Arnold K.S., Newhouse Y.M., Innerarity T.L., Weisgraber K.H.
Nat. Struct. Biol. 3:718-722(1996) · UniProtKB (1) |
| Biosynthesis of apolipoprotein B48-containing lipoproteins. Regulation by novel post-transcriptional mechanisms. Innerarity T.L., Boren J., Yamanaka S., Olofsson S.O.
J. Biol. Chem. 271:2353-2356(1996) · Mapped (4) |
| A unique haplotype of the apolipoprotein B-100 allele associated with familial defective apolipoprotein B-100 in a Chinese man discovered during a study of the prevalence of this disorder. Bersot T.P., Russell S.J., Thatcher S.R., Pomernacki N.K., Mahley R.W., Weisgraber K.H., Innerarity T.L., Fox C.S.
J. Lipid Res. 34:1149-1154(1993) · Mapped (12) |
| Cloning and mutagenesis of the rabbit ApoB mRNA editing protein. A zinc motif is essential for catalytic activity, and noncatalytic auxiliary factor(s) of the editing complex are widely distributed. Yamanaka S., Poksay K.S., Balestra M.E., Zeng G.-Q., Innerarity T.L.
J. Biol. Chem. 269:21725-21734(1994) · UniProtKB (1) |
| Plasma lipoproteins: apolipoprotein structure and function. Mahley R.W., Innerarity T.L., Rall S.C. Jr., Weisgraber K.H.
J. Lipid Res. 25:1277-1294(1984) · Mapped (31) |
| Complete protein sequence and identification of structural domains of human apolipoprotein B. Knott T.C., Pease R.J., Powell L.M., Wallis S.C., Rall S.C. Jr., Innerarity T.L., Blackhart B., Taylor W.R., Marcel Y., Milne R. et al.
Nature 323:734-738(1986) · UniProtKB (1) |
| Human apolipoprotein B: structure of carboxyl-terminal domains, sites of gene expression, and chromosomal localization. Knott T.J., Rall S.C. Jr., Innerarity T.L., Jacobson S.F., Urdea M.S., Levy-Wilson B., Powell L.M., Pease R.J., Eddy R., Nakai H. et al.
Science 230:37-43(1985) · UniProtKB (1) |
| Apoprotein (E--A-II) complex of human plasma lipoproteins. II. Receptor binding activity of a high density lipoprotein subfraction modulated by the apo(E--A-II) complex. Innerarity T.L., Mahley R.W., Weisgraber K.H., Bersot T.P.
J. Biol. Chem. 253:6289-6295(1978) |
